Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSUN
3501
FirstSun Capital Bancorp
FSUN
$1.91B
| $742K | ﹤0.01% |
19,117
-4,797
| -20% | -$181K |
|
3502
Lexeo Therapeutics
LXEO
$324M
| $741K | ﹤0.01% |
111,579
-4,563
| -4% | -$22.1K |
|
|
AVNS
3503
DELISTED
Avanos Medical
AVNS
| $741K | ﹤0.01% |
64,082
-20,090
| -24% | -$235K |
|
3504
Orion Group Holdings
ORN
$396M
| $741K | ﹤0.01% |
89,020
-9,762
| -10% | -$77K |
|
|
ZIMV
3505
DELISTED
ZimVie
ZIMV
| $741K | ﹤0.01% |
39,101
-7,312
| -16% | -$124K |
|
|
MBCN
3506
DELISTED
Middlefield Banc Corp
MBCN
| $740K | ﹤0.01% |
24,674
-1,844
| -7% | -$55.4K |
|
|
KREF
3507
KKR Real Estate Finance Trust
KREF
$448M
| $739K | ﹤0.01% |
82,115
-25,797
| -24% | -$240K |
|
3508
Citi Trends
CTRN
$555M
| $738K | ﹤0.01% |
23,796
-1,219
| -5% | -$39.4K |
|
3509
Voyager Therapeutics
VYGR
$183M
| $738K | ﹤0.01% |
158,109
-13,722
| -8% | -$49.6K |
|
3510
Lennar Class B
LEN.B
$19.4B
| $738K | ﹤0.01% |
6,153
-2,828
| -31% | -$335K |
|
3511
Aquestive Therapeutics
AQST
$463M
| $737K | ﹤0.01% |
131,758
-22,070
| -14% | -$95.4K |
|
3512
AngioDynamics
ANGO
$611M
| $734K | ﹤0.01% |
65,703
-8,202
| -11% | -$79.2K |
|
3513
U-Haul Holding Co
UHAL
$13.9B
| $734K | ﹤0.01% |
12,857
+12,345
| +2,411% | +$728K |
|
|
GRDN
3514
Guardian Pharmacy Services
GRDN
$2.5B
| $734K | ﹤0.01% |
27,973
+2,075
| +8% | +$49.5K |
|
|
NAGE
3515
Niagen Bioscience
NAGE
$271M
| $733K | ﹤0.01% |
78,583
-16,473
| -17% | -$166K |
|
3516
Peapack-Gladstone Financial
PGC
$815M
| $732K | ﹤0.01% |
26,532
-17,196
| -39% | -$482K |
|
3517
Five Star Bancorp
FSBC
$1.14B
| $732K | ﹤0.01% |
22,724
-7,161
| -24% | -$225K |
|
3518
Spok Holdings
SPOK
$228M
| $728K | ﹤0.01% |
42,207
-1,690
| -4% | -$30.1K |
|
3519
AdvanSix
ASIX
$541M
| $728K | ﹤0.01% |
37,554
-13,950
| -27% | -$293K |
|
3520
Tronox
TROX
$932M
| $726K | ﹤0.01% |
180,606
-64,656
| -26% | -$296K |
|
3521
Savers
SVV
$1.58B
| $725K | ﹤0.01% |
54,726
+7,431
| +16% | +$85.4K |
|
|
VTLE
3522
DELISTED
Vital Energy
VTLE
| $725K | ﹤0.01% |
42,917
-431,211
| -91% | -$7.29M |
|
3523
Invesco Mortgage Capital
IVR
$759M
| $724K | ﹤0.01% |
95,816
-34,738
| -27% | -$265K |
|
3524
NWPX Infrastructure Inc
NWPX
$1.19B
| $724K | ﹤0.01% |
13,674
-2,531
| -16% | -$121K |
|
3525
Hingham Institution for Saving
HIFS
$627M
| $724K | ﹤0.01% |
2,743
-1,151
| -30% | -$307K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.